Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Sold by LSV Asset Management

LSV Asset Management lowered its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 14.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 16,444 shares of the medical instruments supplier’s stock after selling 2,771 shares during the quarter. LSV Asset Management owned about 0.45% of Utah Medical Products worth $1,385,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UTMD. WINTON GROUP Ltd acquired a new position in shares of Utah Medical Products in the 3rd quarter valued at about $319,000. Cardinal Capital Management raised its holdings in Utah Medical Products by 1.3% in the 4th quarter. Cardinal Capital Management now owns 11,727 shares of the medical instruments supplier’s stock worth $991,000 after purchasing an additional 146 shares during the period. Natixis Advisors L.P. acquired a new position in Utah Medical Products in the 3rd quarter worth about $1,102,000. Quadrature Capital Ltd raised its holdings in Utah Medical Products by 128.3% in the 3rd quarter. Quadrature Capital Ltd now owns 13,363 shares of the medical instruments supplier’s stock worth $1,156,000 after purchasing an additional 7,510 shares during the period. Finally, Everett Harris & Co. CA raised its holdings in Utah Medical Products by 3.6% in the 4th quarter. Everett Harris & Co. CA now owns 14,828 shares of the medical instruments supplier’s stock worth $1,249,000 after purchasing an additional 517 shares during the period. Institutional investors and hedge funds own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 7th. TheStreet cut Utah Medical Products from a “b-” rating to a “c+” rating in a research note on Monday, February 12th.

Utah Medical Products Stock Up 0.7 %

NASDAQ UTMD opened at $69.45 on Friday. Utah Medical Products, Inc. has a 52-week low of $65.91 and a 52-week high of $100.59. The business’s 50-day moving average price is $68.98 and its 200 day moving average price is $76.32. The firm has a market cap of $249.26 million, a P/E ratio of 15.43 and a beta of 0.15.

Utah Medical Products Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 5th. Investors of record on Friday, June 14th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, June 14th. This represents a $1.20 annualized dividend and a yield of 1.73%. Utah Medical Products’s dividend payout ratio is presently 26.67%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.